A multicenter, double-blind, randomized, parallel-group, placebo-controlled study to evaluate the efficacy and safety of camostat mesilate in patients with COVID-19 (CANDLE study)

T. Kinoshita, Jun‐ichi Kadota|BMC Medicine|2022

Cited by 37